Endotoxin contamination remains a critical challenge in biopharmaceutical manufacturing. Detecting and eliminating these bacterial toxins protects patients and ensures regulatory compliance. With stringent quality control, GMP standards, and advanced testing methods, manufacturers can deliver safe, effective, and high-quality therapies that patients can trust. https://xelleratherapeutics.hashnode.dev/endotoxins-biopharmaceuticals-patient-safety